The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AC1NUOQ4     2-[[(2-amino-1,3-thiazol-4- yl)-[[(3S)-2,2...

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of tigemonam


High impact information on tigemonam


Chemical compound and disease context of tigemonam


Biological context of tigemonam


Anatomical context of tigemonam


Associations of tigemonam with other chemical compounds


Analytical, diagnostic and therapeutic context of tigemonam


  1. In vitro evaluation of tigemonam, a novel oral monobactam. Tanaka, S.K., Summerill, R.A., Minassian, B.F., Bush, K., Visnic, D.A., Bonner, D.P., Sykes, R.B. Antimicrob. Agents Chemother. (1987) [Pubmed]
  2. In vitro antimicrobial activity of tigemonam, a new orally administered monobactam. Fuchs, P.C., Jones, R.N., Barry, A.L. Antimicrob. Agents Chemother. (1988) [Pubmed]
  3. Tigemonam, an oral monobactam. Chin, N.X., Neu, H.C. Antimicrob. Agents Chemother. (1988) [Pubmed]
  4. In vivo evaluation of tigemonam, a novel oral monobactam. Clark, J.M., Olsen, S.J., Weinberg, D.S., Dalvi, M., Whitney, R.R., Bonner, D.P., Sykes, R.B. Antimicrob. Agents Chemother. (1987) [Pubmed]
  5. Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam. van Ogtrop, M.L., Guiot, H.F., Mattie, H., van Strijen, E., Sekh, B.R., van Furth, R. Antimicrob. Agents Chemother. (1991) [Pubmed]
  6. In vitro activity of tigemonam against multiresistant nosocomial Enterobacteriaceae. Giamarellou, H., Pephanis, A., Grammatikou, M., Avlamis, A., Papoulias, G. Journal of chemotherapy (Florence, Italy) (1989) [Pubmed]
  7. Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations. Yourassowsky, E., van der Linden, M.P., Lismont, M.J., Crokaert, F. Journal of chemotherapy (Florence, Italy) (1989) [Pubmed]
  8. In-vitro activity of tigemonam, an oral monobactam, against gram-negative rods, including variants in beta-lactamase-production. Brown, J., Yang, Y.J., Livermore, D.M. J. Antimicrob. Chemother. (1989) [Pubmed]
  9. The in vitro activity of tigemonam: a comparison with other antimicrobial agents. Andrews, J.M., Wise, R. Journal of chemotherapy (Florence, Italy) (1989) [Pubmed]
  10. In vitro activity of tigemonam against urinary tract pathogens. Garcia-Rodriguez, J.A., Garcia-Sanchez, J.E. Journal of chemotherapy (Florence, Italy) (1989) [Pubmed]
  11. Antibacterial activity in vitro of tigemonam, a new oral monobactam. Schito, G.C., Debbia, E., Bandelloni, R., Paglia, P., Pesce, A. Journal of chemotherapy (Florence, Italy) (1989) [Pubmed]
  12. Comparison of the effects of aztreonam and tigemonam against Escherichia coli and Klebsiella pneumoniae in vitro and in vivo. van Ogtrop, M.L., Mattie, H., Guiot, H.F., van Strijen, E., Sekh, B.R., van Furth, R. Antimicrob. Agents Chemother. (1991) [Pubmed]
  13. Comparative in-vitro activity of tigemonam, a new monobactam. Rylander, M., Gezelius, L., Norrby, S.R. J. Antimicrob. Chemother. (1988) [Pubmed]
WikiGenes - Universities